CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 476312-476468
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T74457","span":{"begin":0,"end":156},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This was a multicenter, double-blind, parallel-group, 12-month extension of a 12-week double-blind trial of patients 12 years with severe persistent asthma."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T276","span":{"begin":0,"end":156},"obj":"Sentence"}],"text":"This was a multicenter, double-blind, parallel-group, 12-month extension of a 12-week double-blind trial of patients 12 years with severe persistent asthma."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4672","span":{"begin":5,"end":8},"obj":"Disease"},{"id":"T4673","span":{"begin":149,"end":155},"obj":"Disease"}],"attributes":[{"id":"A4672","pred":"mondo_id","subj":"T4672","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"id":"A4673","pred":"mondo_id","subj":"T4673","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"}],"text":"This was a multicenter, double-blind, parallel-group, 12-month extension of a 12-week double-blind trial of patients 12 years with severe persistent asthma."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T2577","span":{"begin":149,"end":155},"obj":"Phenotype"}],"attributes":[{"id":"A2577","pred":"hp_id","subj":"T2577","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"This was a multicenter, double-blind, parallel-group, 12-month extension of a 12-week double-blind trial of patients 12 years with severe persistent asthma."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1056","span":{"begin":63,"end":72},"obj":"Body_part"}],"attributes":[{"id":"A1056","pred":"uberon_id","subj":"T1056","obj":"http://purl.obolibrary.org/obo/UBERON_2000106"}],"text":"This was a multicenter, double-blind, parallel-group, 12-month extension of a 12-week double-blind trial of patients 12 years with severe persistent asthma."}